Vericel
Steven Dixon is a highly experienced professional in the field of biotechnology, currently serving as a Senior Research & Development Associate at Vericel Corporation since August 2015. At Vericel, Steven leads scientific studies and conducts experiments involving human autologous cells and CSI-3T3 fibroblast cells, while ensuring compliance with FDA standards in an ISO 7 cleanroom environment. Prior roles include Research & Development Associate, Manufacturing Associate II, Manufacturing Associate I, Senior Manufacturing Technician, and Manufacturing Technician, all focusing on aseptic cell culture processes for the Epicel product. Steven also has research experience from the University of Massachusetts Amherst, where arsenic transformation mechanisms were studied, along with internships in analytical laboratories and environmental protection. Steven holds a Master of Science in Biotechnology from the University of Massachusetts Lowell and a Bachelor of Science in Biology from Western New England University.
Vericel
Vericel (NASDAQ:VCEL) develops, manufactures and markets autologous expanded cell therapies for the treatment of patients with serious diseases and conditions